| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/16/2013 | US8486400 Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling |
| 07/16/2013 | US8486391 Cancer treatment kits using antibodies to aminophospholipids |
| 07/16/2013 | US8486382 Method for treating cervical cancer |
| 07/16/2013 | CA2705474C O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates |
| 07/16/2013 | CA2697167C Benzimidazole derivatives used as fxr agonists |
| 07/16/2013 | CA2644841C Use of c-src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia |
| 07/16/2013 | CA2590048C Cytosine nucleoside analogs and isoflavones and uses thereof |
| 07/16/2013 | CA2577222C Isoindoline compounds and methods of making and using the same |
| 07/16/2013 | CA2493888C Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications |
| 07/16/2013 | CA2486106C Compounds and methods for inhibiting selectin-mediated function |
| 07/16/2013 | CA2477283C Vascular therapeutic methods and compositions involving the reduction or prevention of c-jun mediated processes |
| 07/16/2013 | CA2464656C Spray drying methods and compositions thereof |
| 07/16/2013 | CA2458476C Photoreactive compounds and compositions |
| 07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/16/2013 | CA2425665C Coated implantable medical device |
| 07/16/2013 | CA2358684C Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/16/2013 | CA2330231C Composition and method for modulating dendritic cell-t cell interaction |
| 07/16/2013 | CA2289742C Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
| 07/12/2013 | WO2012094540A2 Methods for preparation of glycosphingolipids and uses thereof |
| 07/12/2013 | CA2854725A1 Methods for preparation of glycosphingolipids and uses thereof |
| 07/11/2013 | WO2013103993A1 Therapeutic compounds and related methods of use |
| 07/11/2013 | WO2013103795A1 Bis (thiohydrazide amide) compounds for treating cancers |
| 07/11/2013 | WO2013103707A1 Ligand-targeted molecules and methods thereof |
| 07/11/2013 | WO2013103614A1 Crlf-2 binding peptides, protocells and viral-like particles useful in the treatment of cancer, including acute lymphoblastic leukemia (all) |
| 07/11/2013 | WO2013103424A2 Silk-based multifunctional biomedical platform |
| 07/11/2013 | WO2013103401A1 Methods and compositions for the treatment of cancer |
| 07/11/2013 | WO2013103317A1 Quinoline compounds which are anti-angiogenic integrin alpha5 betal inhibitors for use in the treatment of fibrosis or fibrosis-related diseases |
| 07/11/2013 | WO2013102860A1 Therapeutic use of imidazopyridine derivatives |
| 07/11/2013 | WO2013102825A1 Cdcp1 and breast cancer |
| 07/11/2013 | WO2013102806A1 Calmangafodipir, a new chemical entity, and other mixed metal complexes, methods of preparation, compositions, and methods of treatment |
| 07/11/2013 | WO2013102641A1 Means and methods for treating or diagnosing idh1 r132h mutant-positive cancers |
| 07/11/2013 | WO2013102437A1 Uses of danshen or danshen preparation in preparation of drugs for treating diseases related to hepatic fibrosis |
| 07/11/2013 | WO2013102431A1 Therapeutically active compounds and their methods of use |
| 07/11/2013 | WO2013102290A1 Method for specifically recognizing dna containing 5-methylated cytosine |
| 07/11/2013 | WO2013102289A1 Specific binding and targeting method for dna-rna heteroduplex |
| 07/11/2013 | WO2013102249A1 N-phenylpiperazine derivatives that are antagonists of α1a, α1d adrenoceptors and 5-ht1a receptors for the treatment of benign prostate hyperplasia, pharmaceutical compositions containing the same |
| 07/11/2013 | WO2013102242A1 Heterocyclic compounds and methods for their use |
| 07/11/2013 | WO2013072762A3 Transdermal propranolol patch for treatment of malignant melanoma |
| 07/11/2013 | WO2013068993A3 Tyrosine isomers as therapeutic agents |
| 07/11/2013 | WO2013063679A9 Use of neu1 sialidase inhibitors in the treatment of cancer |
| 07/11/2013 | WO2013059582A3 Small molecule inhibitors of histone deacteylases |
| 07/11/2013 | WO2013019445A3 Anti-angiogenic peptides and uses thereof |
| 07/11/2013 | WO2013019079A3 Composition containing 5-hydroxyindole compounds or sponge scalarispongia sp. extracts as active ingredients for prevention and treatment of cancer diseases |
| 07/11/2013 | WO2013013240A3 Macrocyclic compounds and related compositons and methods of use |
| 07/11/2013 | WO2012177837A3 Novel maytansinoid derivatives with peptide linker and conjugates thereof |
| 07/11/2013 | WO2012171007A3 Methods for treating or preventing graft versus host disease |
| 07/11/2013 | WO2012164398A3 Modulation of the ubiquitin-proteasome system (ups) |
| 07/11/2013 | US20130178624 Quinazoline derivatives |
| 07/11/2013 | US20130178543 Biomarker for diagnosing cancer and method of isolating cancer cell using the same |
| 07/11/2013 | US20130178418 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 07/11/2013 | US20130177650 Pellet formulation for the treatment of the intestinal tract |
| 07/11/2013 | US20130177631 Method and medicament for inhibiting the expression of a given gene |
| 07/11/2013 | US20130177574 ANTI-HLA CLASS-Ib ANTIBODIES MIMIC IMMUNOREACTIVITY AND IMMUNOMODULATORY FUNCTIONS OF INTRAVENOUS IMMUNOGLOBULIN (IVIg) USEFUL AS THERAPEUTIC IVIg MIMETICS AND METHODS OF THEIR USE |
| 07/11/2013 | CA2858427A1 Method of treating cancer by administration of low levels of heat shock protein 70 (hsp70) |
| 07/10/2013 | EP2612921A1 Process for production of novel degalactosylated gc globulin |
| 07/10/2013 | EP2612869A2 The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases |
| 07/10/2013 | EP2612865A2 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 07/10/2013 | EP2612857A1 Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate |
| 07/10/2013 | EP2612856A2 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 07/10/2013 | EP2612853A1 c-Met modulators and methods of use |
| 07/10/2013 | EP2612682A2 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| 07/10/2013 | EP2612675A1 Treatment of development-related disorders |
| 07/10/2013 | EP2612656A1 Process for producing drug block-copolymer composite and pharmaceutical product containing same |
| 07/10/2013 | EP2611920A2 Vesicular stomatitis viruses |
| 07/10/2013 | EP2611918A1 Mirnas involved in the blood brain barrier function |
| 07/10/2013 | EP2611902A2 Compositions and methods for modulating emt and uses thereof |
| 07/10/2013 | EP2611833A1 Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugs |
| 07/10/2013 | EP2611829A2 Novel antigen binding proteins |
| 07/10/2013 | EP2611812A1 Thienopyridine and thienopyrimidine compounds and methods of use thereof |
| 07/10/2013 | EP2611809A1 Azolopyridine and azolopyrimidine compounds and methods of use thereof |
| 07/10/2013 | EP2611808A1 Pyrazolopyridinone derivatives as lpa receptor antagonists |
| 07/10/2013 | EP2611806A1 Deuterium-enriched heterocyclic compounds as kinase inhibitors |
| 07/10/2013 | EP2611804A1 Novel compounds and compositions for the inhibition of nampt |
| 07/10/2013 | EP2611798A1 Pyridazinones, method of making, and method of use thereof |
| 07/10/2013 | EP2611797A2 Quinoline or quinazoline derivatives with apoptosis inducing activity on cells |
| 07/10/2013 | EP2611796A1 An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof |
| 07/10/2013 | EP2611795A1 An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof |
| 07/10/2013 | EP2611794A1 4-azolylaminoquinazoline derivatives and methods of use thereof |
| 07/10/2013 | EP2611793A1 2-cycloquinazoline derivatives and methods of use thereof |
| 07/10/2013 | EP2611792A1 Hydrobromide salts of a pyrazolylaminoquinazoline |
| 07/10/2013 | EP2611790A1 Pyridinones/pyrazinones, method of making, and method of use thereof |
| 07/10/2013 | EP2611789A1 Quinazoline compounds and methods of use thereof |
| 07/10/2013 | EP2611778A1 Guanidine compounds and compositions for the inhibition of nampt |
| 07/10/2013 | EP2611777A1 4- { [ ( pyridin- 3 - yl -methyl) aminocarbonyl]amino} benzene - sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer |
| 07/10/2013 | EP2611462A2 Peptide or peptide complex binding to 2 integrin and methods and uses involving the same |
| 07/10/2013 | EP2611448A1 7-cyclylquinazoline derivatives and methods of use thereof |
| 07/10/2013 | EP2611443A2 Methods for treatment of non-small cell lung cancer |
| 07/10/2013 | EP2611436A1 Combination of hdac inhibitors with thrombocytopenia drugs |
| 07/10/2013 | CN1541109B Inhibitors of HER3 activity |
| 07/10/2013 | CN103201291A Anti single-strand type-iv collagen polypeptide antibody, and pharmaceutical, or agent for diagnosing, preventing or treating tumours, containing same |
| 07/10/2013 | CN103201290A S100a4 antibodies and therapeutic uses thereof |
| 07/10/2013 | CN103201277A Pyridazinones, method of making, and method of use thereof |
| 07/10/2013 | CN103201275A Salt(s) of 7-cyclopentyl-2 -(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof |
| 07/10/2013 | CN103201274A Pyrrolidine derivatives used as cathepsin inhibitors |
| 07/10/2013 | CN103201263A P53-Mdm2 antagonists |
| 07/10/2013 | CN103201262A Autotaxin inhibitors and uses thereof |
| 07/10/2013 | CN103200953A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
| 07/10/2013 | CN103200947A Oncolytic measles virus |
| 07/10/2013 | CN103200943A Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members |
| 07/10/2013 | CN103197067A Cytotoxicity mediation of cells evidencing surface expression of CD44 |